-
New models of kidney cancer may drive immunotherapy research
-
UNC Lineberger member William Y. Kim, MD, and his colleagues report in the journal Nature Communications they have created mouse models of both papillary and clear cell renal cell carcinoma that faithfully mimic the genetic changes seen in tumors of patients with these cancers.
Located in
News
/
2017
/
June
-
New School of Medicine Program Highlights Precision Medicine at UNC
-
The Program for Precision Medicine in Health Care will be led by the UNC School of Medicine’s Jonathan Berg, MD, PhD. The program, funded by a $10-million grant from UNC Health Care, will be a collaboration among multiple departments within the school to bring together existing precision medicine treatments and support future endeavors in this field.
Located in
News
/
2018
/
October
-
New simple test could help cystic fibrosis patients find best treatment
-
In a significant step toward personalized medicine for cystic fibrosis, a minimally-invasive technique developed in the lab of Martina Gentzsch, PhD, shows promise as a fast, inexpensive indicator to help more patients access new treatments.
Located in
News
/
2017
/
November
-
New therapeutic gel shows promise against cancerous tumors
-
The lab of Zhen Gu, PhD, in the joint UNC-NC State biomedical engineering department developed a biodegradable hydrogel scaffold system to release chemotherapeutic and immunotherapeutic drugs at the tumor site.
Located in
News
/
2018
/
February
-
Newly designed viral vectors could lead to improved gene therapies
-
UNC and University of Florida researchers created viruses to deliver gene therapies while evading pre-existing immune system responses. Aravind Asokan, PhD, led the research team at UNC.
Located in
News
/
2017
/
June
-
Newsweek Lists UNC Medical Center & UNC REX Among World’s Best Hospitals
-
UNC Medical Center is ranked #50 in the United States, UNC REX is #148 on Newsweek's inaugural list of The World's Best Hospitals.
Located in
News
/
2019
/
March
-
Pancreatic cancer tumor classification could optimize treatment choices
-
UNC Lineberger’s Jen Jen Yeh, MD, and Naim Rashid, PhD, reported findings on how two subtypes of pancreatic cancer respond to treatments differently. Importantly, they found that one subtype of the disease showed poor responses to common therapies, and also had worse survival rates.
Located in
News
/
2019
/
November
-
Patients Notified of Privacy Incident at UNC Dermatology & Skin Cancer Center in Burlington, NC
-
Affecting Patients Seen by the “Burlington Dermatology Center” through September 2015.
Located in
News
/
2017
/
December
-
Payments linked to higher odds of doctors prescribing certain cancer drugs
-
In preliminary findings that will be presented at the American Society of Clinical Oncology Annual Meeting 2017 in Chicago on Saturday, June 3, researchers show that when physicians had to choose between multiple, on-patent drugs for metastatic kidney cancer and chronic myeloid leukemia, they were more likely to prescribe drugs from companies they had received general payments from.
Located in
News
/
2017
/
June
-
Phenotyping may lead to more tailored treatment for head and neck cancer
-
Fourth-year medical student Wesley Stepp, PhD, has developed a testing method to predict aggressiveness of head and neck cancers and help physicians determine the ideal treatment regimen.
Located in
News
/
2018
/
April